Literature DB >> 1254988

Activity of combinations of antimicrobial agents against Bacteroides fragilis.

D F Busch, V L Sutter, S M Finegold.   

Abstract

Thirty-two clinical isolates of Bacteroides fragilis were tested against nine pairs of antimicrobial agents by means of an agar dilution technique. A synergistic effect was observed with the combination of clindamycin and metronidazole. End points were achieved with 17 strains. Of these strains, 13 (76%) were inhibited by the combination of clindamycin and metronidazole; each drug was present at a concentration of less than or equal to 25% of its minimal inhibitory concentration when tested alone. This combination also showed synergistic bactericidal activity against three of six strains examined by a tube dilution technique. No antagonism was noted with any strain. The other eight combinations tested failed to show a consistent synergistic effect, although no antagonism was observed. These in vitro data indicate that antagonism is not likely to be encountered when combination therapy is used for B. fragilis infections. For selected B. fragilis infections, the combination of clindamycin and metronidazole may be useful.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1254988     DOI: 10.1093/infdis/133.3.321

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Synergistic action of erythromycin and cefamandole against Bacteroides fragilis subsp. fragilis.

Authors:  R S Griffith; G L Brier; J D Wolny
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

2.  Access of metronidazole into the chronically inflamed middle ear with reference to anaerobic bacterial infections.

Authors:  L Jokipii; P Karma; A M Jokipii
Journal:  Arch Otorhinolaryngol       Date:  1978-06-27

Review 3.  Bacterial synergy in pelvic inflammatory disease.

Authors:  I Brook
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

4.  Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods.

Authors:  J Wust
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

Review 5.  Clinical pharmacokinetics of metronidazole.

Authors:  E D Ralph
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

6.  Potentially synergistic antimicrobial combinations with metronidazole against Bacteroides fragilis.

Authors:  E D Ralph; Y E Amatnieks
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

7.  Successful antimicrobial therapy of hepatic, intra-abdominal and intrapelvic abscesses.

Authors:  E D Ralph
Journal:  Can Med Assoc J       Date:  1984-09-15       Impact factor: 8.262

8.  Effect of antibiotics on the prevention of experimental Bacteroides fragilis endocarditis.

Authors:  P L Goldman; D T Durack; R G Petersdorf
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

9.  Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.

Authors:  I Brook; J C Coolbaugh; R I Walker; E Weiss
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

Review 10.  Antimicrobial drugs used in the management of anaerobic infections in children.

Authors:  I Brook
Journal:  Drugs       Date:  1983-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.